HOLYPHARM

  • Home
  • |
  • Products
  • |
  • About Us
  • |
  • News
  • |
  • Contact Us
English
  • 中文
  • English
  • 日本語
  • 한국어
  • Español
  • Français
NEWS
文章附图

Study on the kidney benefits of semaglutide

2025-07-22
In recent years, GLP-1 receptor agonists have gained significant attention in diabetes and weight management. Among them, semaglutide stands out not only for its excellent glycemic and weight control
NEWS
文章附图

Tirzepatide: A Dual Agonist Redefining Metabolic Disease Treatment

2025-07-22
Tirzepatide is a novel peptide drug developed by Eli Lilly, approved by the FDA for the treatment of type 2 diabetes, and shows strong potential in weight management. Unlike traditional GLP-1 receptor
NEWS
文章附图

Overview of Citric Acid Functions

2025-07-22
Citric acid is a naturally occurring organic acid found widely in citrus fruits. It was first isolated from lemon juice in 1784 by Swedish chemist Carl Wilhelm Scheele. With the molecular formula C₆H₈
NEWS
Hangzhou HolyPharm Biotech Co.,ltd
Science and Innovation for a Healthier Life
CONTACT US
Address: T2-805, European and American Financial City, Cangqian Street, Yuhang District, Hangzhou, China.
Email: info@holypharm.com
Tel: +86-0571-8875 2329
FOLLOW US

©2025 Hangzhou HolyPharm Biotech Co.,ltd Copyright

Powered by:Powered by ECHEMILoginsitemap